Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator

NCT: NCT07526935 · ACTIVE_NOT_RECRUITING

NCT IDNCT07526935
StatusACTIVE_NOT_RECRUITING
Start Date2025-03-19
Completion2028-12-30

Brief Summary

This study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.

Frequently Asked Questions

What is Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator?

Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator is a clinical trial registered under NCT07526935. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07526935?

The current status of NCT07526935 (Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator) is: ACTIVE_NOT_RECRUITING.

When did Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator start?

Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator started on 2025-03-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑